PlexusDx takes a different approachleveraging compounded medications from licensed 503A pharmacies paired with optional genetic testing to support more tailored provider conversations about peptide pathway predispositions and individual variation
Low awareness of GLP-1s globally, but high in the most advanced economies Despite media discussions around the drugs, only around a third across 30 countries have heard about the drugs, with a lot of the discourse taking place via social media according to the Ipsos Health Service Report
& Betz, H
Week 3-4: First Weight Loss Emerges What happens mechanistically: Sustained caloric reduction begins producing measurable fat loss
Jacova C, Pearce LA, Costello R, McClure LA, Holliday SL, Hart RG, Benavente OR
Who should never take a GLP-1 Dr